Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor

Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor

Blink Device Company announces the launch of the TwitchView®2 System, the second generation of its electromyographic (EMG) quantitative neuromuscular monitoring system. A complete redesign based on experience in over 1,000,000 clinical cases around the world. Designed to withstand OR abuse and to perform reliably in even the most difficult-to-monitor patients.  - August 14, 2024

TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade

TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade

ASA guideline first author Dr. Stephan Thilen et al. reports exciting results from a protocol that completely eliminated post-operative residual neuromuscular blockade (PRNMB). Of note, Thilen et al. achieved this groundbreaking advance in patient safety using the TwitchView® Train of Four (TOF) monitor while maintaining a role for neostigmine as a reversal strategy, resulting in pharmacologic cost savings of $42 per patient. - May 30, 2023

Blink Device Company Announces Launch of GelAuto™ Wearable Hand Gel System

Blink Device Company Announces Launch of GelAuto™ Wearable Hand Gel System

Blink Device Company launches the GelAuto™ wearable smart hand gel system. The Gelauto is an app controlled system that allows users to control gel volume, set reminders and track gel frequency of single users and groups. - September 22, 2020

New Study Confirms TwitchView® Quantitative Monitor for Neuromuscular Blockade is Comparable to Gold Standard Mechanomyography

New Study Confirms TwitchView® Quantitative Monitor for Neuromuscular Blockade is Comparable to Gold Standard Mechanomyography

Blink Device Company announced today that a study comparing the TwitchView® quantitative train-of-four (TOF) electromyography-based monitor to accelerometry and mechanomyography has been published in the journal Anaesthesia (https://onlinelibrary.wiley.com/doi/10.1111/anae.14872). The results... - October 18, 2019

Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Major Electronic Medical Records

Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Major Electronic Medical Records

Blink Device Company announced today that the TwitchView™ quantitative train-of-four (TOF) monitor now integrates with most major electronic medical records (EMR). Commercially available in the United States, Europe, and South Korea, the TwitchView™ neuromuscular TOF monitor uses... - June 04, 2019

Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesiologists Annual Meeting

Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesiologists Annual Meeting

Presents Clinical Validation Data Establishing Equivalence to Gold Standard - October 10, 2018

Medical Device Manufacturer Blink Device Company Signs Distribution Agreement with KCPMED

Medical Device Manufacturer Blink Device Company Signs Distribution Agreement with KCPMED

KCPMED Appointed Exclusive South Korean Distributor for TwitchView™ Neuromuscular Monitor. - September 05, 2018

Blink Device Company Receives CE Mark for TwitchView™ Quantitative Monitor for Neuromuscular Blockade; Debuts at European Society of Anaesthesiology Meeting

Blink Device Company Receives CE Mark for TwitchView™ Quantitative Monitor for Neuromuscular Blockade; Debuts at European Society of Anaesthesiology Meeting

Blink Device Company announced today that it has received a CE Mark for TwitchView, its novel, user-friendly, quantitative monitor for neuromuscular blockade. With this certification, the company plans to launch the product into the European market, first appearing at the 2018 European Society of... - June 01, 2018

Medical Device Startup Blink Device Company Announces 510(k) Clearance of TwitchView Quantitative Monitor for Neuromuscular Blockade and Hires VP of Sales and Marketing

Medical Device Startup Blink Device Company Announces 510(k) Clearance of TwitchView Quantitative Monitor for Neuromuscular Blockade and Hires VP of Sales and Marketing

Blink Device Company, a recently formed medical device company helmed by industry veterans, aims to support clinicians with practical, cutting-edge technologies and never-before-seen reliability. Their recently 510(k) cleared product, TwitchView, is an objective monitor for neuromuscular blockade,... - April 26, 2018

Press Releases 1 - 9 of 9